Abstract
No public abstract is available from the verified source records.
Qin Ouyang, 周信文, Jieyi Shi, Long Liao, Cun Wang
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Hepatocellular carcinoma
10.1038/s41572-020-00240-3 · 2021
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
10.1038/s41571-023-00825-3 · 2023
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
10.1016/j.jhep.2021.11.018 · 2022
Evolving therapeutic landscape of advanced hepatocellular carcinoma
10.1038/s41575-022-00704-9 · 2023
Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications
10.1038/s41388-023-02702-w · 2023
Sweet Surprises: Decoding Tumor-Associated Glycosylation in Cancer Progression and Therapeutic Potential
10.3390/cells15030233 · 2026
The Biological Basis and Analyses of N-Glycan Microheterogeneity
10.1016/j.mcpro.2025.101491 · 2026
Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis
10.1038/s41467-019-09222-w · 2019
N-linked protein glycosylation in the endoplasmic reticulum
10.1101/cshperspect.a013359 · 2013
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
Factors controlling the glycosylation potential of the Golgi apparatus
10.1016/s0962-8924(97)01198-7 · 1998
Expanding N-glycopeptide identifications by modeling fragmentation, elution, and glycome connectivity
10.1038/s41467-024-50338-5 · 2024
pGlycoQuant with a deep residual network for quantitative glycoproteomics at intact glycopeptide level
10.1038/s41467-022-35172-x · 2022
Uncovering missing glycans and unexpected fragments with pGlycoNovo for site-specific glycosylation analysis across species
10.1038/s41467-024-52099-7 · 2024
Precise, fast and comprehensive analysis of intact glycopeptides and modified glycans with pGlyco3
10.1038/s41592-021-01306-0 · 2021
Decoding the glycoproteome: a new frontier for biomarker discovery in cancer
10.1186/s13045-024-01532-x · 2024
The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States
10.1016/j.cgh.2022.01.047 · 2023
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
10.1016/j.cell.2019.08.052 · 2019
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
10.1038/s42255-022-00710-w · 2023
Targeting mutant p53 for efficient cancer therapy
10.1038/nrc.2017.109 · 2018
P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure
10.1186/s13321-018-0285-8 · 2018
The role of N-glycosylation in cancer
10.1016/j.apsb.2023.10.014 · 2024
QuPath: Open source software for digital pathology image analysis
10.1038/s41598-017-17204-5 · 2017
A Golgi UDP-GlcNAc transporter delivers substrates for N-linked glycans and sphingolipids
10.1038/s41477-018-0235-5 · 2018
TMEM241 is a UDP-N-acetylglucosamine transporter required for M6P modification of NPC2 and cholesterol transport
10.1016/j.jlr.2023.100465 · 2023
Nucleotide Sugar Transporter SLC35 Family Structure and Function
10.1016/j.csbj.2019.08.002 · 2019
Structural Characterization of Glycoprotein Glycans and Glycosaminoglycans of Brain Tissues in Slc35a3-Knockout Mice
10.3390/ijms27041643 · 2026
Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis
10.1038/s41598-023-51028-w · 2024
No additional external references are available.